| - GRCh37:
- Chr3:158567751-160802139
| IL12A, IQCJ, ARL14, B3GALNT1, C3orf80, IFT80, IQCJ-SCHIP1, KPNA4, PPM1L, SCHIP1, SMC4, TRIM59 | | Growth abnormality | Uncertain significance (Apr 9, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:145461209-146467333
| ANKRD34A, ANKRD35, CD160, GPR89A, ITGA10, LIX1L, NBPF11, NBPF12, NUDT17, PDZK1, PEX11B, PIAS3, POLR3C, POLR3GL, RBM8A, RNF115 | | Growth abnormality | Uncertain significance (Apr 9, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:173401888-174124738
| GAS5, RC3H1, SERPINC1, SLC9C2, ZBTB37, KLHL20, PRDX6, ANKRD45, CENPL, DARS2 | | Growth abnormality | Uncertain significance (Apr 9, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:144124843-144680183
| NBPF8, PPIAL4A | | Growth abnormality | Uncertain significance (Apr 9, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:163753-687906
| GEMIN4, GLOD4, LIAT1, MRM3, RFLNB, RPH3AL, TLCD3A, VPS53 | | Growth abnormality | Uncertain significance (Apr 9, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:37617331-37737185
| CDK12 | | Growth abnormality | Uncertain significance (Apr 9, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:131761639-131761642
- GRCh38:
- Chr10:129963375-129963378
| EBF3 | E94fs | Recurrent urinary tract infections, Vesicoureteral reflux, Generalized hypotonia, Growth abnormality, Abnormal facial shape, Constipation, Global developmental delay, Hypotonia, ataxia, and delayed development syndrome | Pathogenic (Feb 7, 2017) | no assertion criteria provided |